OpenAlex
PricingAboutJobs
Log inGet started
Work

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer’s disease

HTML

Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
DOI: 10.1212/wnl.52.6.1146
Authors: L.J. Thal, J.M. Ferguson, J. Mintzer, A. Raskin, S.D. Targum
Institutions: Medical University of South Carolina, University of California San Diego
Language: English

Topic: Dementia and Cognitive Impairment Research
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, acetylcholinesterase inhibitors, cognitive function, functional status, gastrointestinal adverse effects, agitation, dose titration, drug safety and efficacy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2023967416
FWCI: 7.478
Cites: 22
Cited by: 76
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security